ℹ️ Skipped - page is already crawled
| Filter | Status | Condition | Details |
|---|---|---|---|
| HTTP status | PASS | download_http_code = 200 | HTTP 200 |
| Age cutoff | PASS | download_stamp > now() - 6 MONTH | 2 months ago |
| History drop | PASS | isNull(history_drop_reason) | No drop reason |
| Spam/ban | PASS | fh_dont_index != 1 AND ml_spam_score = 0 | ml_spam_score=0 |
| Canonical | PASS | meta_canonical IS NULL OR = '' OR = src_unparsed | Not set |
| Property | Value |
|---|---|
| URL | https://www.axios.com/2021/12/04/pfizer-vaccine-kids-under-five |
| Last Crawled | 2026-02-12 21:07:15 (2 months ago) |
| First Indexed | 2022-05-06 16:44:29 (3 years ago) |
| HTTP Status Code | 200 |
| Meta Title | Pfizer could have vaccine data for children under five by end of 2021, CEO says |
| Meta Description | Omicron has raised concerns that young children are becoming more vulnerable to the virus. |
| Meta Canonical | null |
| Boilerpipe Text | Shawna Chen
A health care worker administers a dose of the Pfizer-BioNTech COVID vaccine to a child at a Salvation Army vaccination clinic in Philadelphia on Nov. 12. Photo: Hannah Beier/Bloomberg via Getty Images
Pfizer could have data on COVID-19 vaccine efficacy for children under five by the end of the year, CEO Albert Bourla said on Friday in an
interview with NBC News
.
Why it matters:
Omicron has raised concerns that young children are becoming more vulnerable to the virus. Tshwane, the epicenter of South Africa's Omicron outbreak, has seen a high number of hospital admissions for children under two in the last few weeks, though scientists have not confirmed a link to the variant,
Reuters reports
.
What they're saying:
"We have a study in children 6 months to 2 years and then another cohort of children 2 to 5 years," Bourla said. "So [by] end of the year, beginning of next year, when we see the data, we will know more."
Moderna is also testing its vaccine among children, though it's unclear when the data will become available, according to NBC News.
Worth noting:
The U.S. Food and Drug Administration 0n Friday
authorized the emergency use
of Eli Lilly's COVID antibody therapy treatment for children under 12 who test positive and are at risk of severe illness. |
| Markdown | Manage your tracker preferences
We use cookies and similar tracking technologies to remember preferences, analyze traffic, and deliver ads. Using some kinds of trackers (like cross-site or behavioral advertising cookies) may be considered a “sale” or “sharing” of personal data under certain state laws. You can opt in or out of these trackers below.
Targeted advertising cookies and similar trackers
On
Setting this to “off” disables targeted advertising and related trackers in your current browser. To fully opt out, you must disable tracking on each browser and device you use. Clearing cookies may reset your preferences. Because we can't link your Axios subscriber account (email) to browser cookies, you may also want to update your settings in the Privacy Center to ensure your account is fully opted out. See our Privacy Policy for more on how we use personal data and your rights. Review our Privacy Policy at axios.com/legal for more on how we use personal data and your rights.
Save
[Privacy Center](https://privacy.axios.com/)
[Powered by](https://ethyca.com/)
[Skip to main content](https://www.axios.com/2021/12/04/pfizer-vaccine-kids-under-five#main-content)
- [Newsletters](https://www.axios.com/newsletters)
- Axios Local
Show
- [Axios Pro](https://www.axios.com/pro/all-deals)
- [Axios Live](https://www.axios.com/events)
- [The Axios Show](https://www.axios.com/the-axios-show)
Login
[Axios](https://www.axios.com/)
All topics
[Axios](https://www.axios.com/)
Search
Dec 3, 2021 - [Health](https://www.axios.com/health)
# Pfizer could have vaccine data for children under five by end of 2021, CEO says
- [Shawna Chen](https://www.axios.com/authors/schen)
- facebook (opens in new window)
- twitter (opens in new window)
- linkedin (opens in new window)
- email (opens in new window)
- sms (opens in new window)
[Add Axios on Google](https://google.com/preferences/source?q=axios.com)
Add Axios as your preferred source to
see more of our stories on Google.
[Add Axios on Google](https://google.com/preferences/source?q=axios.com)
A health care worker administers a dose of the Pfizer-BioNTech COVID vaccine to a child at a Salvation Army vaccination clinic in Philadelphia on Nov. 12. Photo: Hannah Beier/Bloomberg via Getty Images
Pfizer could have data on COVID-19 vaccine efficacy for children under five by the end of the year, CEO Albert Bourla said on Friday in an [interview with NBC News](https://www.nbcnews.com/health/health-news/pfizer-vaccine-data-kids-age-5-year-end-ceo-says-rcna7602).
**Why it matters:** Omicron has raised concerns that young children are becoming more vulnerable to the virus. Tshwane, the epicenter of South Africa's Omicron outbreak, has seen a high number of hospital admissions for children under two in the last few weeks, though scientists have not confirmed a link to the variant, [Reuters reports](https://www.reuters.com/business/healthcare-pharmaceuticals/does-omicron-pose-higher-risks-infants-than-other-variants-2021-12-01/).
**What they're saying:** "We have a study in children 6 months to 2 years and then another cohort of children 2 to 5 years," Bourla said. "So \[by\] end of the year, beginning of next year, when we see the data, we will know more."
- Moderna is also testing its vaccine among children, though it's unclear when the data will become available, according to NBC News.
**Worth noting:** The U.S. Food and Drug Administration 0n Friday [authorized the emergency use](https://www.fda.gov/news-events/press-announcements/fda-expands-authorization-two-monoclonal-antibodies-treatment-and-post-exposure-prevention-covid-19) of Eli Lilly's COVID antibody therapy treatment for children under 12 who test positive and are at risk of severe illness.
- facebook (opens in new window)
- twitter (opens in new window)
- linkedin (opens in new window)
- email (opens in new window)
- sms (opens in new window)
[Add Axios on Google](https://google.com/preferences/source?q=axios.com)
##### What to read next
- 
- 
- 
- 
- 
Smarter, faster on what matters.
[Explore Axios Newsletters](https://www.axios.com/newsletters)
- [About Axios](https://www.axios.com/about)
- [Advertise with us](https://www.axios.com/advertise)
- [Careers](https://www.axios.com/careers)
- [Contact us](https://www.axios.com/contact)
- [Newsletters](https://www.axios.com/newsletters)
- [Axios Live](https://www.axios.com/events)
- [Axios HQ](https://www.axioshq.com/?utm_source=axios&utm_medium=site&utm_campaign=axioshq)
- [Privacy policy](https://www.axios.com/legal)
- [Terms of use](https://www.axios.com/legal/terms-of-use)
- Your Privacy Choices
[Axios Homepage](https://www.axios.com/)
Axios Media Inc., 2026
 |
| Readable Markdown | 
- [Shawna Chen](https://www.axios.com/authors/schen)
A health care worker administers a dose of the Pfizer-BioNTech COVID vaccine to a child at a Salvation Army vaccination clinic in Philadelphia on Nov. 12. Photo: Hannah Beier/Bloomberg via Getty Images
Pfizer could have data on COVID-19 vaccine efficacy for children under five by the end of the year, CEO Albert Bourla said on Friday in an [interview with NBC News](https://www.nbcnews.com/health/health-news/pfizer-vaccine-data-kids-age-5-year-end-ceo-says-rcna7602). **Why it matters:** Omicron has raised concerns that young children are becoming more vulnerable to the virus. Tshwane, the epicenter of South Africa's Omicron outbreak, has seen a high number of hospital admissions for children under two in the last few weeks, though scientists have not confirmed a link to the variant, [Reuters reports](https://www.reuters.com/business/healthcare-pharmaceuticals/does-omicron-pose-higher-risks-infants-than-other-variants-2021-12-01/).
**What they're saying:** "We have a study in children 6 months to 2 years and then another cohort of children 2 to 5 years," Bourla said. "So \[by\] end of the year, beginning of next year, when we see the data, we will know more." Moderna is also testing its vaccine among children, though it's unclear when the data will become available, according to NBC News. **Worth noting:** The U.S. Food and Drug Administration 0n Friday [authorized the emergency use](https://www.fda.gov/news-events/press-announcements/fda-expands-authorization-two-monoclonal-antibodies-treatment-and-post-exposure-prevention-covid-19) of Eli Lilly's COVID antibody therapy treatment for children under 12 who test positive and are at risk of severe illness. |
| Shard | 115 (laksa) |
| Root Hash | 8292587546678785315 |
| Unparsed URL | com,axios!www,/2021/12/04/pfizer-vaccine-kids-under-five s443 |